Project Grant K08CA283306
Award Date
7/1/24
Completion Date
6/30/29
Dollars Obligated
$210K
Federal Agency
National Cancer Institute
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $256,487 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Sloan-Kettering Institute for Cancer Research. The grant supports a 5-year research project to develop multimodal predictive models that integrate real-world data from circulating tumor DNA sequencing, tumor genomics, medical imaging, and clinical notes to improve risk stratification and clinical management of non-small cell lung cancer (NSCLC). The research aims...
This federal Project Grant award of $358,000.00 was provided by the National Cancer Institute (NCI), which administers the Cancer Cause and Prevention Research (CFDA 93.393) program. The grant supports research at Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, to characterize and address non-response in patient-reported outcomes (PRO) data collected as part of routine cancer care. The key objectives are to: 1) Characterize non-response in PRO data...
This $2,372,456 federal Project Grant awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports a multi-year, multi-institutional research initiative to leverage observational (real-world) data to advance precision oncology. The principal investigator is Dr. Charles Sawyers of Memorial Sloan Kettering Cancer Center. The project involves four highly integrated research initiatives: (1) overcoming methodological barriers in...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) will fund the development and evaluation of an interactive visual aid (VIS) to facilitate patient-clinician communication and shared decision-making around stopping cancer treatment in advanced cancer care. The $257,413 award, effective August 1, 2024 through July 31, 2029, will allow the principal investigator and their team at Dartmouth-Hitchcock Clinic to: 1) assess patient-caregiver-clinician...
The National Cancer Institute (NCI) awarded a $563,130 Project Grant under the Cancer Research Manpower program (CFDA 93.398) to the University of California, Davis. The grant, effective August 1, 2024 through November 30, 2029, aims to identify barriers and facilitators for delivering guideline-concordant care to adolescent and young adult (AYA) patients with Ewing sarcoma and osteosarcoma. The key objectives are to: 1) Identify barriers and facilitators to delivering guideline-concordant...
This Project Grant award from the National Cancer Institute's Cancer Research Manpower (CFDA 93.398) program provides $182,236 to New York University School of Medicine to adapt and pilot test an evidence-based sexual health communication skills training intervention for prostate cancer patients. The key objectives are to: Conduct focus groups and interviews to identify barriers and facilitators to patient-provider communication about sexual health in prostate cancer care, and use this...
This federal Project Grant award for $519,048.00 was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The grant recipient, Sloan-Kettering Institute for Cancer Research, will use the funding to conduct research focused on dissecting the role of the FOSL1 transcription factor in mediating lineage plasticity and resistance to androgen receptor signaling inhibition in prostate cancer. The research aims to define the mechanisms by which...
This $2,282,687 federal Project Grant award was made by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393). The grant supports a multi-year research program to understand how different forms of care integration (structural, functional, normative, interpersonal, and process) in oncology practices are associated with quality of care and patient outcomes, including for marginalized populations. The research program involves four interrelated...
The National Cancer Institute (NCI) has awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $293,053 Project Grant under the Cancer Research Manpower (CFDA 93.398) program. The five-year grant, with an award date of August 15, 2024, will fund the refinement and pilot testing of a supportive psychosocial intervention for patients with malignant primary central nervous system (CNS) tumors. The intervention incorporates elements of Acceptance and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower program) for $273,211 will support the development, refinement, and proof-of-concept testing of the Reproductive and Sexual Health Patient Education and Communication Tool (RESPECT). RESPECT is a novel, patient-centered, web-based intervention that aims to improve sexual and reproductive health (SRH) communication between adolescent and young adult (AYA) oncology patients and their...